Authors

• Massimo Filippi (ORCID: https://orcid.org/0000-0002-5485-0479)
• Veronica Castelnovo
• Elisa Canu (ORCID: https://orcid.org/0000-0001-5804-3378)
• Edoardo Gioele Spinelli (ORCID: https://orcid.org/0000-0003-1492-7221)
• Federica Agosta (ORCID: https://orcid.org/0000-0003-3121-4979)
• Vincenzo Silani (ORCID: https://orcid.org/0000-0002-7698-3854)
• Ildebrando Marco Appollonio (ORCID: https://orcid.org/0000-0003-4717-6479)
• Silvia Torre (ORCID: https://orcid.org/0000-0002-2039-3644)
• Tommaso Russo (ORCID: https://orcid.org/0000-0003-4426-0106)
• Federico Verde (ORCID: https://orcid.org/0000-0002-3977-6995)
• Yuri Falzone (ORCID: https://orcid.org/0000-0003-3233-1907)
• Barbara Poletti (ORCID: https://orcid.org/0000-0003-4398-2051)
• Lucio Tremolizzo
• Paride Schito (ORCID: https://orcid.org/0000-0002-7152-4472)
• Silvia Basaia (ORCID: https://orcid.org/0000-0002-0722-6243)
• Nicola Ticozzi
• Fabiola Freri

Institutions

• Vita-Salute San Raffaele University (IT)
• University of Milan (IT)
• IRCCS Ospedale San Raffaele (IT)
• IRCCS Istituto Auxologico Italiano (IT)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• Ferrari (Italy) (IT)
• Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
• University of Milano-Bicocca (IT)

Publication Details

Journal

Journal of Neurology

Published

2025-07-14

DOI

https://doi.org/10.1007/s00415-025-13247-1

Primary Topic

Amyotrophic Lateral Sclerosis Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bristol-Myers Squibb
• Eli Lilly and Company
• Sanofi
• Biogen
• Teva Pharmaceutical Industries
• Alexion Pharmaceuticals
• Celgene
• Fondazione Italiana Sclerosi Multipla
• EU Joint Programme – Neurodegenerative Disease Research
• E-Rare
• Ministero della Salute
• Novo Nordisk
• Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
• Ministero dell'Università e della Ricerca
• Novartis Pharma
• H2020 European Research Council